Clinical Trials · NCT02956447
Administration of Kisspeptin in Patients With Hyperprolactinemia
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 36
- Start date
- Nov 2017
- Locations
- 1 site, United States
- Primary endpoint
- Average Change in Number of Luteinizing Hormone (LH) Pulses Over 10 Hours